David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
LeMaitre Vascular
LMAT
$1.83B
| $518K | ﹤0.01% |
9,129
-27,796
| -75% | -$1.46M |
|
3352
Invesco S&P 500 GARP ETF
SPGP
$2.31B
| $515K | ﹤0.01% |
+5,255
| New | +$486K |
|
3353
PUT
MP Materials
MP
$10.6B
| $514K | ﹤0.01% |
+25,900
| New | +$442K |
|
3354
Dime Commercial Bancshares
DCOM
$1.78B
| $512K | ﹤0.01% |
19,021
-25,837
| -58% | -$553K |
|
3355
Cable One
CABO
$147M
| $512K | ﹤0.01% |
919
| – | – |
|
3356
United Fire Group
UFCS
$1.37B
| $511K | ﹤0.01% |
25,418
-3,441
| -12% | -$69.8K |
|
3357
Financial Institutions
FISI
$801M
| $509K | ﹤0.01% |
23,878
-16,166
| -40% | -$288K |
|
|
NARI
3358
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $506K | ﹤0.01% |
+7,800
| New | +$470K |
|
3359
iShares US Regional Banks ETF
IAT
$663M
| $506K | ﹤0.01% |
+12,100
| New | +$434K |
|
3360
Gentex
GNTX
$4.99B
| $503K | ﹤0.01% |
15,415
-126,322
| -89% | -$3.9M |
|
3361
MediaAlpha
MAX
$774M
| $503K | ﹤0.01% |
45,144
-26,043
| -37% | -$258K |
|
3362
Powell Industries
POWL
$6.99B
| $503K | ﹤0.01% |
17,070
-4,692
| -22% | -$131K |
|
3363
iShares Core S&P Total US Stock Market ETF
ITOT
$97B
| $502K | ﹤0.01% |
+4,766
| New | +$467K |
|
|
GOLD
3364
Gold.com Inc
GOLD
$1.33B
| $501K | ﹤0.01% |
16,573
+3,467
| +26% | +$98.8K |
|
3365
EVgo
EVGO
$213M
| $499K | ﹤0.01% |
+139,500
| New | +$413K |
|
3366
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $499K | ﹤0.01% |
+10,710
| New | +$462K |
|
3367
CALL
Murphy USA
MUSA
$10.1B
| $499K | ﹤0.01% |
+1,400
| New | +$507K |
|
3368
Cullinan Oncology
CGEM
$1.47B
| $498K | ﹤0.01% |
48,919
+9,217
| +23% | +$81.7K |
|
3369
Anavex Life Sciences
AVXL
$324M
| $498K | ﹤0.01% |
53,454
+20,913
| +64% | +$144K |
|
|
SMAR
3370
DELISTED
Smartsheet Inc.
SMAR
| $494K | ﹤0.01% |
10,327
-77,053
| -88% | -$3.28M |
|
3371
ICF International
ICFI
$1.59B
| $493K | ﹤0.01% |
3,676
+833
| +29% | +$109K |
|
3372
Novavax
NVAX
$1.56B
| $492K | ﹤0.01% |
102,533
+86,936
| +557% | +$532K |
|
|
ONC
3373
BeOne Medicines Ltd
ONC
$42.9B
| $492K | ﹤0.01% |
+2,727
| New | +$493K |
|
3374
Moelis & Co
MC
$5B
| $492K | ﹤0.01% |
8,759
+3,035
| +53% | +$143K |
|
|
NBIS
3375
CALL
Nebius Group N.V.
NBIS
$59.5B
| $491K | ﹤0.01% |
30,000
| – | – |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.